Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder

por Balog, Brian M., Tangada, Abhilasha, Sheth, Pooja, Song, Qi-Xiang, Couri, Bruna M., Porras, Leah L., Deng, Gary G., Damaser, Margot S.
Publicado 2019

Selective Phosphodiesterase 1 Inhibitor BTTQ Reduces Blood Pressure in Spontaneously Hypertensive and Dahl Salt Sensitive Rats: Role of Peripheral Vasodilation

por Dey, Asim B., Khedr, Sherif, Bean, James, Porras, Leah L., Meredith, Tamika D., Willard, Francis S., Hass, Joseph V., Zhou, Xin, Terashvili, Maia, Jesudason, Cynthia D., Ruley, Kevin M., Wiley, Michael R., Kowala, Mark, Atkinson, Simon J., Staruschenko, Alexander, Rekhter, Mark D.
Publicado 2020

Effects of pharmacological inhibition of the sodium‐dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models

por Wang, Xiaojun, Xu, Yanping, Yu, Xiaohong, Dey, Asim, Zhang, Hong Y., Zink, Charity M., Wodka, Derek, Porter, Gina, Matter, William F., Porras, Leah, Reidy, Charles A., Peterson, Jeffrey A., Mattioni, Brian E., Haas, Joseph V., Kowala, Mark C., Wetterau, John R.
Publicado 2022